Evidence map›Paper›PMID 35194894›Full record

SynthesisDermatologic therapy2022

Cutaneous adverse reactions of COVID-19 vaccines: A systematic review.

Kowsar Qaderi, Mohammad Hossein Golezar, Abbas Mardani, Manthar Ali Mallah, Bagher Moradi, Hossein Kavoussi, Ahmadreza Shamsabadi, Samira Golezar

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Dermatologic therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 4 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 4 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Alopecia areata following COVID-19 vaccine: a systematic review.European journal of medical research · 2024
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. The immunogenicity and safety of adenoviral-based vaccines.Current opinion in allergy and clinical immunology · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Cutaneous reactions to vaccination.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Kowsar QaderiDepartment of Midwifery, Faculty of Nursing and Midwifery, Kermanshah University of Medical Sciences (KUMS), Kermanshah, Iran.ORCID 0000-0002-6233-8117
Mohammad Hossein GolezarMedical Students Research Committee, Shahed University, Tehran, Iran.
Abbas MardaniNursing Care Research Center, Department of Medical Surgical Nursing, School of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran.
Manthar Ali MallahCollege of Public Health, Zhengzhou University, Zhengzhou, China.ORCID 0000-0003-1037-9440
Bagher MoradiDepartment of Health Information Technology, Esfarayen Faculty of Medical Science, Esfarayen, Iran.ORCID 0000-0002-3875-2510
Hossein KavoussiDermatology Department, Kermanshah University of Medical Sciences (KUMS), Kermanshah, Iran.
Ahmadreza ShamsabadiDepartment of Health Information Technology, Esfarayen Faculty of Medical Science, Esfarayen, Iran.
Samira GolezarDepartment of Midwifery, Faculty of Nursing and Midwifery, Kermanshah University of Medical Sciences (KUMS), Kermanshah, Iran.
Kermanshah University of Medical Sciences · IREsfarayen University of Technology · IRIran University of Medical Sciences · IRShahed University · IRZhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Numerous vaccines are under clinical development and implementation for the prevention of severe course and lethal outcomes of coronavirus disease 2019 (COVID-19). This systematic review aims to summarize and integrated the findings of studies regarding cutaneous side effects of COVID-19 vaccines. This systematic review conducted by searching the scientific databases of PubMed, Scopus, Science direct, and Web of knowledge from the beginning of the COVID-19 to May 10, 2021. Articles were reviewed and analyzed based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist. Seventeen studies on cutaneous side effects of COVID-19 vaccines were included after the screening of search results based on to the eligibility criteria. The results showed that the most common injection site reactions and delayed large local reactions, arising from all vaccine types, were redness/erythema (39%), followed by: itchiness (28%), urticarial rash (17%) on the neck, upper limbs, and trunk, morbilliform eruptions (6.5%), Pityriasis rosea (3%), swelling, and burning, and so forth. Most cutaneous reactions occurred in women (84%), and middle-aged people, after the first dose of vaccine, with the onset ranged from 1 to 21 days after vaccination. In addition, cutaneous reactions were generally self-limiting, and needed little or no therapeutic intervention, that were not regarded as a barrier to injecting a second dose. In conclusion, severe cutaneous side effects are very rare and approved vaccines have satisfactory safety profiles. Therefore, mild or moderate cutaneous reactions should not discourage people from vaccination. In certain groups such as patients with allergies and a history of local injection reactions, pre-vaccination counseling and assurance, also use of appropriate medications may be helpful. However, more studies are needed to investigate the side effect profile of all COVID-19 vaccines.

Indexed as

COVID-19Drug-Related Side Effects and Adverse ReactionsVaccinesCOVID-19 VaccinesFemaleHumansMiddle AgedSkinVaccinationCOVID-19 VaccinesVaccinesadverse eventCOVID-19cutaneousdermatologicexanthemaSARS-CoV-2skinvaccines

Identifiers

PMID35194894
PMCPMC9111405
OpenAlexW4212850343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.